Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Frailty and subclinical coronary atherosclerosis: The Multicenter AIDS Cohort Study (MACS).

Korada SKC, Zhao D, Tibuakuu M, Brown TT, Jacobson LP, Guallar E, Bolan RK, Palella FJ, Margolick JB, Martinson JJ, Budoff MJ, Post WS, Michos ED.

Atherosclerosis. 2017 Nov;266:240-247. doi: 10.1016/j.atherosclerosis.2017.08.026. Epub 2017 Aug 26.

PMID:
28886899
2.

Lipid levels in HIV-positive men receiving anti-retroviral therapy are not associated with copy number variation of reverse cholesterol transport pathway genes.

Marino RB, Kingsley LA, Hussain SK, Bream JH, Penogonda S, Duggal P, Martinson JJ.

BMC Res Notes. 2015 Nov 21;8:697. doi: 10.1186/s13104-015-1665-z.

3.

No association between Apoε4 alleles, HIV infection, age, neuropsychological outcome, or death.

Becker JT, Martinson JJ, Penugonda S, Kingsley L, Molsberry S, Reynolds S, Aronow A, Goodkin K, Levine A, Martin E, Miller EN, Munro CA, Ragin A, Sacktor N.

J Neurovirol. 2015 Feb;21(1):24-31. doi: 10.1007/s13365-014-0290-2. Epub 2014 Nov 12.

4.

The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status.

Estrella MM, Li M, Tin A, Abraham AG, Shlipak MG, Penugonda S, Hussain SK, Palella FJ Jr, Wolinsky SM, Martinson JJ, Parekh RS, Kao WH.

Clin Infect Dis. 2015 Feb 15;60(4):646-52. doi: 10.1093/cid/ciu765. Epub 2014 Oct 3.

5.

HIV therapy, metabolic and cardiovascular health are associated with glomerular hyperfiltration among men with and without HIV infection.

Ng DK, Jacobson LP, Brown TT, Palella FJ Jr, Martinson JJ, Bolan R, Miller ER 3rd, Schwartz GJ, Abraham AG, Estrella MM.

AIDS. 2014 Jan 28;28(3):377-86. doi: 10.1097/QAD.0000000000000094.

6.

Increases in duration of first highly active antiretroviral therapy over time (1996-2009) and associated factors in the Multicenter AIDS Cohort Study.

Slama L, Li X, Brown T, Jacobson LP, Pialoux G, Macatangay B, Bolan RK, Phair J, Palella FJ Jr; Multicenter AIDS cohort Study.

J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):57-64. doi: 10.1097/QAI.0b013e3182a99a0d.

7.

Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.

Rotger M, Glass TR, Junier T, Lundgren J, Neaton JD, Poloni ES, van 't Wout AB, Lubomirov R, Colombo S, Martinez R, Rauch A, Günthard HF, Neuhaus J, Wentworth D, van Manen D, Gras LA, Schuitemaker H, Albini L, Torti C, Jacobson LP, Li X, Kingsley LA, Carli F, Guaraldi G, Ford ES, Sereti I, Hadigan C, Martinez E, Arnedo M, Egaña-Gorroño L, Gatell JM, Law M, Bendall C, Petoumenos K, Rockstroh J, Wasmuth JC, Kabamba K, Delforge M, De Wit S, Berger F, Mauss S, de Paz Sierra M, Losso M, Belloso WH, Leyes M, Campins A, Mondi A, De Luca A, Bernardino I, Barriuso-Iglesias M, Torrecilla-Rodriguez A, Gonzalez-Garcia J, Arribas JR, Fanti I, Gel S, Puig J, Negredo E, Gutierrez M, Domingo P, Fischer J, Fätkenheuer G, Alonso-Villaverde C, Macken A, Woo J, McGinty T, Mallon P, Mangili A, Skinner S, Wanke CA, Reiss P, Weber R, Bucher HC, Fellay J, Telenti A, Tarr PE; MAGNIFICENT Consortium; INSIGHT; Swiss HIV Cohort Study.

Clin Infect Dis. 2013 Jul;57(1):112-21. doi: 10.1093/cid/cit196. Epub 2013 Mar 26.

8.

HAART-associated dyslipidemia varies by biogeographical ancestry in the multicenter AIDS cohort study.

Nicholaou MJ, Martinson JJ, Abraham AG, Brown TT, Hussain SK, Wolinsky SM, Kingsley LA.

AIDS Res Hum Retroviruses. 2013 Jun;29(6):871-9. doi: 10.1089/AID.2012.0169. Epub 2013 Mar 8.

9.

Replication of RYR3 gene polymorphism association with cIMT among HIV-infected whites.

Shrestha S, Yan Q, Joseph G, Arnett DK, Martinson JJ, Kingsley LA.

AIDS. 2012 Jul 31;26(12):1571-3. doi: 10.1097/QAD.0b013e328355359f.

10.

Copy number variation of KIR genes influences HIV-1 control.

Pelak K, Need AC, Fellay J, Shianna KV, Feng S, Urban TJ, Ge D, De Luca A, Martinez-Picado J, Wolinsky SM, Martinson JJ, Jamieson BD, Bream JH, Martin MP, Borrow P, Letvin NL, McMichael AJ, Haynes BF, Telenti A, Carrington M, Goldstein DB, Alter G; NIAID Center for HIV/AIDS Vaccine Immunology.

PLoS Biol. 2011 Nov;9(11):e1001208. doi: 10.1371/journal.pbio.1001208. Epub 2011 Nov 29. Erratum in: PLoS Biol. 2011 Dec;9(12). doi:10.1371/annotation/7e17b146-a69c-4e83-9230-7340486d9dc8.

11.

Investigation of association between PFO complicated by cryptogenic stroke and a common variant of the cardiac transcription factor GATA4.

Moradi Marjaneh M, Kirk EP, Posch MG, Ozcelik C, Berger F, Hetzer R, Otway R, Butler TL, Blue GM, Griffiths LR, Fatkin D, Martinson JJ, Winlaw DS, Feneley MP, Harvey RP.

PLoS One. 2011;6(6):e20711. doi: 10.1371/journal.pone.0020711. Epub 2011 Jun 6.

12.

Factors affecting brain structure in men with HIV disease in the post-HAART era.

Becker JT, Maruca V, Kingsley LA, Sanders JM, Alger JR, Barker PB, Goodkin K, Martin E, Miller EN, Ragin A, Sacktor N, Selnes O; Multicenter AIDS Cohort Study.

Neuroradiology. 2012 Feb;54(2):113-21. doi: 10.1007/s00234-011-0854-2. Epub 2011 Mar 22.

13.

Subcortical brain atrophy persists even in HAART-regulated HIV disease.

Becker JT, Sanders J, Madsen SK, Ragin A, Kingsley L, Maruca V, Cohen B, Goodkin K, Martin E, Miller EN, Sacktor N, Alger JR, Barker PB, Saharan P, Carmichael OT, Thompson PM; Multicenter AIDS Cohort Study.

Brain Imaging Behav. 2011 Jun;5(2):77-85. doi: 10.1007/s11682-011-9113-8.

14.

Screening low-frequency SNPS from genome-wide association study reveals a new risk allele for progression to AIDS.

Le Clerc S, Coulonges C, Delaneau O, Van Manen D, Herbeck JT, Limou S, An P, Martinson JJ, Spadoni JL, Therwath A, Veldink JH, van den Berg LH, Taing L, Labib T, Mellak S, Montes M, Delfraissy JF, Schächter F, Winkler C, Froguel P, Mullins JI, Schuitemaker H, Zagury JF.

J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):279-84. doi: 10.1097/QAI.0b013e318204982b.

15.

Longitudinal psychomotor speed performance in human immunodeficiency virus-seropositive individuals: impact of age and serostatus.

Sacktor N, Skolasky RL, Cox C, Selnes O, Becker JT, Cohen B, Martin E, Miller EN; Multicenter AIDS Cohort Study (MACS).

J Neurovirol. 2010 Oct;16(5):335-41. doi: 10.3109/13550284.2010.504249.

16.

Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort study.

Wong HL, Breen EC, Pfeiffer RM, Aissani B, Martinson JJ, Margolick JB, Kaslow RA, Jacobson LP, Ambinder RF, Chanock S, Martínez-Maza O, Rabkin CS.

AIDS. 2010 Apr 24;24(7):1025-33. doi: 10.1097/QAD.0b013e328332d5b1. Erratum in: AIDS. 2010 Jul 31;24(12):1973.

17.

Common genetic variation and the control of HIV-1 in humans.

Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, Cirulli ET, Urban TJ, Zhang K, Gumbs CE, Smith JP, Castagna A, Cozzi-Lepri A, De Luca A, Easterbrook P, Günthard HF, Mallal S, Mussini C, Dalmau J, Martinez-Picado J, Miro JM, Obel N, Wolinsky SM, Martinson JJ, Detels R, Margolick JB, Jacobson LP, Descombes P, Antonarakis SE, Beckmann JS, O'Brien SJ, Letvin NL, McMichael AJ, Haynes BF, Carrington M, Feng S, Telenti A, Goldstein DB; NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI).

PLoS Genet. 2009 Dec;5(12):e1000791. doi: 10.1371/journal.pgen.1000791. Epub 2009 Dec 24.

18.

HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection.

Khurana S, Norris PJ, Busch MP, Haynes BF, Park S, Sasono P, Mlisana K, Salim AK, Hecht FM, Mulenga J, Chomba E, Hunter E, Allen S, Nemo G, Rodriguez-Chavez IR; Women's Interagency HIV Study Collaborative Study Group, Margolick JB; Multicenter AIDS Cohort Study (MACS), Golding H.

J Clin Microbiol. 2010 Jan;48(1):281-5. doi: 10.1128/JCM.01573-09. Epub 2009 Nov 11.

19.

CCL3L1 and HIV/AIDS susceptibility.

Urban TJ, Weintrob AC, Fellay J, Colombo S, Shianna KV, Gumbs C, Rotger M, Pelak K, Dang KK, Detels R, Martinson JJ, O'Brien SJ, Letvin NL, McMichael AJ, Haynes BF, Carrington M, Telenti A, Michael NL, Goldstein DB.

Nat Med. 2009 Oct;15(10):1110-2. doi: 10.1038/nm1009-1110. No abstract available.

20.

MIF (macrophage migration inhibitory factor) promoter polymorphisms and susceptibility to severe malarial anemia.

Awandare GA, Martinson JJ, Were T, Ouma C, Davenport GC, Ong'echa JM, Wang W, Leng L, Ferrell RE, Bucala R, Perkins DJ.

J Infect Dis. 2009 Aug 15;200(4):629-37. doi: 10.1086/600894.

Supplemental Content

Loading ...
Support Center